SWOT Analysis for Bharat Parenterals Ltd.

Best results last week in YoY net profit and revenue growth
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Turnaround Companies: Loss to Profit QoQ
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
RSI indicating price strength
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Red Flag: High Interest Payments Compared to Earnings
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Declining profitability: Falling ROCE

Stocks rising sharply on very low month volumes

Rising Delivery Percentage Compared to Prev Day
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Declining Net Cash Flow and Cash from Operating Activity for last 2 years

Bharat Parenterals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats